+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transcriptomics Technologies Market - Global Forecast to 2030- Product Image
Transcriptomics Technologies Market - Global Forecast to 2030- Product Image
Sale

Transcriptomics Technologies Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4985965
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transcriptomics Technologies Market grew from USD 8.48 billion in 2024 to USD 9.64 billion in 2025. It is expected to continue growing at a CAGR of 13.20%, reaching USD 17.86 billion by 2030.

Executive Overview of Transcriptomics Technologies Advancements

The evolving landscape of transcriptomics technologies stands at the forefront of life science innovation. Driven by breakthroughs in molecular biology, bioinformatics, and instrumentation, transcriptomics platforms have transitioned from traditional gene expression assays to highly multiplexed, spatially resolved, and single-cell-level analyses. This summary provides a concise yet comprehensive overview of the critical developments that are shaping research and clinical applications today. It highlights the major technological advancements, regulatory and trade dynamics affecting supply chains, granular insights into market segmentation, regional adoption patterns, and the competitive environment. By weaving together these perspectives, decision-makers can gain a strategic understanding of where the transcriptomics field is headed and how to position their organizations for sustained growth.

Through an authoritative lens, this document explores transformative shifts in methodology and application areas, evaluates the cumulative impact of recent tariff policies in the United States, and distills actionable guidance for stakeholders seeking to navigate complexity. The subsequent sections delve into segmentation by technology type, application areas, end-user categories, and product types; examine key regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific; and offer competitive intelligence on the leading companies driving innovation. Finally, it concludes with targeted recommendations for leaders and a call to action to engage with our sales and marketing team for full market research insights.

Transformative Shifts Reshaping Transcriptomics Technologies Landscape

Over the past five years, several transformative forces have converged to reshape the transcriptomics landscape. First, the maturation of single-cell RNA sequencing and the emergence of spatial transcriptomics have enabled researchers to dissect cellular heterogeneity with unprecedented resolution. These advancements are complemented by digital PCR, which offers absolute quantification of low-abundance transcripts, and renewed interest in in situ hybridization modalities that preserve tissue context.

Second, integration of artificial intelligence and machine learning into data analysis pipelines has accelerated biomarker discovery and predictive modeling. Coupled with expanded cloud-based platforms, this integration has reduced turnaround times and democratized access to high-throughput data processing. Moreover, the drive toward multi-omics integration-linking transcriptomic profiles with proteomic, epigenomic, and metabolomic data-has fostered holistic insights into disease mechanisms and agricultural traits.

Finally, modular instrumentation and reagent kits have become more customizable, enabling rapid protocol adaptations for emerging research needs. Together, these shifts underline a broader trend: laboratories are moving away from one-size-fits-all solutions toward agile, scalable workflows that can be tailored to specific experimental designs, regulatory requirements, and budgetary constraints.

Cumulative Impact of United States Tariffs 2025 on Transcriptomics Market

In 2025, the introduction of new U.S. tariffs on imported reagents, consumables, and instrumentation has introduced a layer of complexity for transcriptomics stakeholders. Laboratories dependent on overseas manufacturing have faced increased procurement costs for kits, probes, and sequencing instruments, leading to tighter capital allocations and renegotiations with suppliers.

Consequently, several organizations have accelerated efforts to diversify supply chains by sourcing from domestic producers or establishing joint ventures with local manufacturers. This strategic pivot has not only mitigated short-term financial burdens but also reinforced regional resilience against future trade disputes. Simultaneously, some providers have passed incremental costs onto end users, prompting research institutions and biotech companies to reevaluate project budgets and timelines.

Despite these headwinds, the long-term impact may prove constructive: suppliers are investing in onshore production capabilities, reducing dependency on complex global logistics networks, and improving lead times. As a result, the market is likely to emerge with a more balanced supply ecosystem, offering procurement flexibility and fostering innovation in reagent formulation and instrument design.

Key Insights Across Technology, Application, End-User, and Product Segments

An integrated view of technology, application, end-user, and product segments reveals nuanced growth trajectories across the transcriptomics market. From a technology type perspective, RNA sequencing-encompassing single-cell, small RNA, and total RNA approaches-continues to command the largest share, while in situ hybridization, subdivided into chromogenic and fluorescence methods, is gaining renewed traction in spatial biology studies. Microarray platforms, both DNA and protein variants, retain niche use cases in high-throughput screening, and northern blotting, via quantitative and traditional formats, remains relevant for targeted validation workflows. Digital and real-time PCR are further enabling precise detection in diagnostic and research settings.

By application, transcriptomics finds expanding roles in agriculture and food industry efforts, such as crop improvement and food safety screening, while disease diagnosis segments, including cancer and neurological disorders testing, benefit from high sensitivity and multiplexing. The drug discovery domain relies on biomarker discovery and target identification pipelines, and personalized medicine initiatives increasingly leverage drug response evaluation and genetic therapy personalization to tailor treatments.

End-user adoption patterns vary: academic and research institutes engage in both basic and translational research, driving methodological innovation; agri-genomics organizations focus on animal and crop genetic testing; hospitals and clinical labs deploy advanced pathology and routine diagnostics; and pharmaceutical and biotechnology companies integrate transcriptomics into clinical trials and early-stage R&D.

Product offerings span consumables and reagents-ranging from kits and assays to probes and primers-alongside a spectrum of instruments, including detection and sequencing platforms, complemented by data analysis software and technical support services. Each product category evolves in response to user demand for workflow efficiency, data accuracy, and regulatory compliance.

Regional Dynamics Driving Transcriptomics Technology Adoption Globally

Regional dynamics underscore distinct drivers and challenges in the transcriptomics arena. In the Americas, the United States leads adoption, propelled by robust federal funding for genomics research and extensive pharma-biotech pipelines, while Canada emphasizes public-private partnerships in agricultural genomics. Europe, Middle East & Africa presents a heterogeneous picture: Western Europe benefits from harmonized regulatory frameworks and established research consortia, whereas emerging markets in the Middle East and Africa are investing in capacity building to address food security and infectious disease surveillance.

Asia-Pacific stands out as a high-growth region, with China and Japan ramping up domestic manufacturing of reagents and instruments, India advancing low-cost diagnostic solutions, and Australia forging international collaborations in single-cell and spatial transcriptomics. Across these regions, factors such as intellectual property regimes, reimbursement policies, and local talent pools continue to shape adoption curves and infrastructure investments.

Leading Players Shaping the Transcriptomics Industry Terrain

The competitive landscape is defined by established life science giants and specialized innovators. Agilent Technologies Inc. and Thermo Fisher Scientific Inc. leverage broad portfolios of instruments and reagents, while Illumina Inc. remains synonymous with high-throughput sequencing. Danaher Corporation extends its reach through strategic acquisitions, and Bio-Rad Laboratories, Inc. focuses on enhancing digital PCR and detection systems. Qiagen N. V. and Promega Corporation continuously refine consumable offerings, and Sigma Aldrich Corporation bolsters its catalog of molecular biology reagents.

On the diagnostics front, BioMérieux SA emphasizes microbial transcriptomics applications, whereas Eurofins Scientific SE offers comprehensive testing services across clinical and agricultural segments. Niche players like Cenix BioScience GmbH, GenXPro GmbH, LC Sciences LLC, and Lexogen GmbH advance specialized protocols for small RNA and targeted sequencing. Sequentia Biotech SL pioneers novel spatial transcriptomics platforms, and Takara Holdings, Inc. invests heavily in single-cell workflow optimization. Collectively, these companies drive innovation via product enhancements, strategic partnerships, and expanded technical support networks.

Actionable Recommendations for Industry Leaders to Navigate Market Complexities

To capitalize on emerging opportunities and mitigate supply chain volatility, industry stakeholders should prioritize the following actions. First, invest in next-generation and spatial transcriptomics platforms to unlock high-resolution data sets, and integrate digital PCR capabilities for precision quantification. Second, diversify sourcing strategies by establishing relationships with domestic and regional suppliers, and explore co-development agreements to localize production of key reagents and consumables.

Third, expand data analysis infrastructure by adopting cloud-native bioinformatics tools and fostering in-house expertise in machine learning. Fourth, pursue strategic collaborations with academic centers, contract research organizations, and agricultural research institutes to accelerate application development in disease diagnostics, crop improvement, and food safety. Fifth, tailor market entry strategies to regional nuances-leveraging favorable regulatory environments in Western Europe, prioritizing capacity building in the Middle East & Africa, and tapping high-growth potential across China, India, and Australia.

Finally, build multidisciplinary teams that blend molecular biology, computational sciences, and regulatory affairs to streamline product development and commercial deployment. By executing these recommendations, organizations can strengthen their competitive positioning and drive sustained value creation.

Concluding Perspectives on the Future of Transcriptomics Technologies

In summary, the transcriptomics space is undergoing a dynamic transformation fueled by innovations in single-cell analysis, spatial mapping, digital quantification, and integrated data science. Trade policy shifts have underscored the importance of resilient supply chains and onshore manufacturing, while segmentation insights highlight diverse growth pockets across technologies, applications, end users, and products. Regional assessments point to varied adoption drivers and investment priorities from the Americas to Europe, the Middle East & Africa, and Asia-Pacific, and the competitive landscape blends the scale of established corporations with the agility of specialized providers.

Organizations that align R&D investments with emerging methodological trends, shore up procurement frameworks against policy risk, and foster collaborative networks will be best positioned to lead in both research and commercial domains. With the transcriptomics market at a pivotal juncture, embracing innovation, operational agility, and strategic partnerships is key to unlocking the full potential of gene expression analysis.

Market Segmentation & Coverage

This research report categorizes the Transcriptomics Technologies Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • In Situ Hybridization
    • Chromogenic In Situ Hybridization
    • Fluorescence In Situ Hybridization
  • Microarray
    • DNA Microarray
    • Protein Microarray
  • Northern Blotting
    • Quantitative Northern Blotting
    • Traditional Northern Blotting
  • PCR
    • Digital PCR
    • Real-Time PCR
  • RNA Sequencing
    • Single-Cell RNA Sequencing
    • Small RNA Sequencing
    • Total RNA Sequencing
  • Agriculture and Food Industry
    • Crop Improvement
    • Food Safety
  • Disease Diagnosis
    • Cancer Diagnostics
    • Neurological Disorders Diagnostics
  • Drug Discovery
    • Biomarker Discovery
    • Target Identification
  • Personalized Medicine
    • Drug Response Evaluation
    • Genetic Therapy Personalization
  • Academic and Research Institutes
    • Basic Research
    • Translational Research
  • Agri-genomics Organizations
    • Animal Genetic Testing
    • Crop Genetic Testing
  • Hospitals and Clinical Testing Labs
    • Advanced Pathology Testing
    • Routine Diagnostics
  • Pharmaceutical and Biotechnology Companies
    • Clinical Trials
    • Research and Development
  • Consumables and Reagents
    • Kits and Assays
    • Probes and Primers
  • Instruments
    • Detection Instruments
    • Sequencing Instruments
  • Software and Services
    • Data Analysis Software
    • Technical Support Services

This research report categorizes the Transcriptomics Technologies Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Transcriptomics Technologies Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • BioMérieux SA
  • Cenix BioScience GmbH
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd
  • GenXPro GmbH
  • Illumina Inc.
  • LC Sciences LLC
  • Lexogen GmbH
  • Promega Corporation
  • Qiagen N. V.
  • Sequentia Biotech SL
  • Sigma Aldrich Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Transcriptomics Technologies Market, by Technology Type
8.1. Introduction
8.2. In Situ Hybridization
8.2.1. Chromogenic In Situ Hybridization
8.2.2. Fluorescence In Situ Hybridization
8.3. Microarray
8.3.1. DNA Microarray
8.3.2. Protein Microarray
8.4. Northern Blotting
8.4.1. Quantitative Northern Blotting
8.4.2. Traditional Northern Blotting
8.5. PCR
8.5.1. Digital PCR
8.5.2. Real-Time PCR
8.6. RNA Sequencing
8.6.1. Single-Cell RNA Sequencing
8.6.2. Small RNA Sequencing
8.6.3. Total RNA Sequencing
9. Transcriptomics Technologies Market, by Application
9.1. Introduction
9.2. Agriculture and Food Industry
9.2.1. Crop Improvement
9.2.2. Food Safety
9.3. Disease Diagnosis
9.3.1. Cancer Diagnostics
9.3.2. Neurological Disorders Diagnostics
9.4. Drug Discovery
9.4.1. Biomarker Discovery
9.4.2. Target Identification
9.5. Personalized Medicine
9.5.1. Drug Response Evaluation
9.5.2. Genetic Therapy Personalization
10. Transcriptomics Technologies Market, by End-User
10.1. Introduction
10.2. Academic and Research Institutes
10.2.1. Basic Research
10.2.2. Translational Research
10.3. Agri-genomics Organizations
10.3.1. Animal Genetic Testing
10.3.2. Crop Genetic Testing
10.4. Hospitals and Clinical Testing Labs
10.4.1. Advanced Pathology Testing
10.4.2. Routine Diagnostics
10.5. Pharmaceutical and Biotechnology Companies
10.5.1. Clinical Trials
10.5.2. Research and Development
11. Transcriptomics Technologies Market, by Product Type
11.1. Introduction
11.2. Consumables and Reagents
11.2.1. Kits and Assays
11.2.2. Probes and Primers
11.3. Instruments
11.3.1. Detection Instruments
11.3.2. Sequencing Instruments
11.4. Software and Services
11.4.1. Data Analysis Software
11.4.2. Technical Support Services
12. Americas Transcriptomics Technologies Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Transcriptomics Technologies Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Transcriptomics Technologies Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Agilent Technologies Inc.
15.3.2. Bio-Rad Laboratories, Inc.
15.3.3. BioMérieux SA
15.3.4. Cenix BioScience GmbH
15.3.5. Danaher Corporation
15.3.6. Eurofins Scientific SE
15.3.7. F. Hoffmann La Roche Ltd
15.3.8. GenXPro GmbH
15.3.9. Illumina Inc.
15.3.10. LC Sciences LLC
15.3.11. Lexogen GmbH
15.3.12. Promega Corporation
15.3.13. Qiagen N. V.
15.3.14. Sequentia Biotech SL
15.3.15. Sigma Aldrich Corporation
15.3.16. Takara Holdings, Inc.
15.3.17. Thermo Fisher Scientific Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. TRANSCRIPTOMICS TECHNOLOGIES MARKET MULTI-CURRENCY
FIGURE 2. TRANSCRIPTOMICS TECHNOLOGIES MARKET MULTI-LANGUAGE
FIGURE 3. TRANSCRIPTOMICS TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. TRANSCRIPTOMICS TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. TRANSCRIPTOMICS TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TRANSCRIPTOMICS TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CHROMOGENIC IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY QUANTITATIVE NORTHERN BLOTTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TRADITIONAL NORTHERN BLOTTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SINGLE-CELL RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SMALL RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TOTAL RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NEUROLOGICAL DISORDERS DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG RESPONSE EVALUATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GENETIC THERAPY PERSONALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ANIMAL GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CROP GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ADVANCED PATHOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ROUTINE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY KITS AND ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PROBES AND PRIMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DETECTION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNICAL SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 136. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 137. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 138. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 139. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 140. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 141. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 142. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 144. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 145. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 146. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 147. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 149. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 150. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 151. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 152. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 154. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 155. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 156. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 157. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 158. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 159. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 160. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 161. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 162. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 164. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 165. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 166. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 167. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 170. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 172. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 174. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 175. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 238. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 239. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 240. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 241. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 242. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 243. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 244. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 246. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 247. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 248. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 249. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 251. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 252. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 253. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 254. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 256. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 257. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 258. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 259. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 260. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 261. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 262. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 263. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 264. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 266. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 267. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 268. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 269. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 271. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 272. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 273. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 274. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 276. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 277. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY NORTHERN BLOTTING, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRICULTURE AND FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 289. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 290. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 291. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY AGRI-GENOMICS ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 292. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY HOSPITALS AND CLINICAL TESTING LABS, 2018-2030 (USD MILLION)
TABLE 293. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 294. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. INDONESIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 296. INDONESIA TRANSCRIPT

Companies Mentioned

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • BioMérieux SA
  • Cenix BioScience GmbH
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd
  • GenXPro GmbH
  • Illumina Inc.
  • LC Sciences LLC
  • Lexogen GmbH
  • Promega Corporation
  • Qiagen N. V.
  • Sequentia Biotech SL
  • Sigma Aldrich Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

RNA Analysis/Transcriptomics Market by Product, Technology, Application, End-User - Global Forecast 2025-2030 - Product Image

RNA Analysis/Transcriptomics Market by Product, Technology, Application, End-User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Spatial Genomics & Transcriptomics Market - Global Forecast to 2030 - Product Image

Spatial Genomics & Transcriptomics Market - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Spatial Transcriptomics Market Size, Share & Trends Analysis Report by Products (Instruments, Consumables, Software), Technology (Sequencing-Based Methods), Workflow, Sample Type, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Spatial Transcriptomics Market Size, Share & Trends Analysis Report by Products (Instruments, Consumables, Software), Technology (Sequencing-Based Methods), Workflow, Sample Type, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 119 Pages
  • Global
From
Spatial Transcriptomics & Genomics Market - Global Outlook & Forecast 2025-2030 - Product Image

Spatial Transcriptomics & Genomics Market - Global Outlook & Forecast 2025-2030

  • Report
  • 362 Pages
  • Global
From
Spatial Genomics and Transcriptomics Market Report and Forecast 2024-2032 - Product Image

Spatial Genomics and Transcriptomics Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From

About the Transcriptomics Market

The Transcriptomics market is a segment of the biotechnology industry that focuses on the study of gene expression. It involves the analysis of the transcriptome, which is the set of all RNA molecules in a cell. This includes mRNA, tRNA, and rRNA. Transcriptomics is used to study gene expression, regulation, and function. It is used to identify and characterize genes, as well as to understand the role of genes in disease and development. Transcriptomics can also be used to identify biomarkers for diagnosis and prognosis, and to develop new therapeutic targets. Some companies in the Transcriptomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.